SFDA-2023-0017-V017

Type IA variation for application SFDA-2023-0017. Type IA variation: Facility Change for Thymosilib — major revision

Variation Number
SFDA-2023-0017-V017
Type
Type IA
Application
SFDA-2023-0017
Change
CHG-2024-0017
Status
Active
Fee
€2,338
Submitted
—
Approved
—
Description

Type IA variation: Facility Change for Thymosilib — major revision